Latest News

ICR scientists uncover information about genetic causes of brain cancer

ICR scientists uncover information about genetic causes of brain cancer

Perrigo completes sale of Tysabri drug royalty to RPI for $2.85bn

Drug manufacturer Perrigo has completed the sale of its right to the royalty stream from the global net sales of the drug Tysabri (natalizumab) to Royalty Pharma's (RPI) affiliate RPI Finance...

Perrigo completes sale of Tysabri drug royalty to RPI for $2.85bn

EC approves Pfizer's Xeljanz to treat rheumatoid arthritis in EU

EC approves Pfizer's Xeljanz to treat rheumatoid arthritis in EU

Leukaemia CARE’s research finds inequalities in cancer care for elderly patients

UK charity Leukaemia CARE has conducted new research into the lives of older people living with blood cancers and revealed inequalities in cancer care for elderly patients compared with those...

Leukaemia CARE’s research finds inequalities in cancer care for elderly patients

PureTech Health and Novartis to advance clinical-stage programmes

US-based PureTech Health has signed a licensing and equity agreement with Swiss company Novartis to advance two clinical-stage programmes targeting the mechanistic target of rapamycin complex...

PureTech Health and Novartis to advance clinical-stage programmes

Merck and Pfizer secure US FDA approval for Bavencio to treat skin cancer

Merck and Pfizer secure US FDA approval for Bavencio to treat skin cancer

M&As this week: Sun Moral International (HK), Immuno Holding

Sun Moral International (HK), a subsidiary of Chinese pharmaceutical company Sihuan Pharmaceutical Holdings Group, has acquired the entire equity interest in Ambest Pharmaceutical (China)...

M&As this week: Sun Moral International (HK), Immuno Holding

Cancer Research UK to support Precision Panc project for pancreatic cancer

Cancer Research UK to support Precision Panc project for pancreatic cancer

Alexion submits application to Japan’s MHLW to extend Soliris indication to treat gMG

Alexion Pharmaceuticals has submitted an application to extend the indication for Soliris (eculizumab) as a potential treatment for patients with refractory generalised myasthenia gravis...

Alexion submits application to Japan’s MHLW to extend Soliris indication to treat gMG

RGC, UK Biobank and GSK launch new initiative to improve disease diagnosis

Regeneron Genetics Center (RGC), UK Biobank and GSK have launched a gene sequencing initiative on the world's detailed health...

RGC, UK Biobank and GSK launch new initiative to improve disease diagnosis

Deals this week: Ascend Therapeutics US, Tyme Technologies, Axsome Therapeutics

Ascend Therapeutics US will be the exclusive seller and marketer of Aevum Life Science’s Protiva Pregnancy and Protiva New Mom / Recover products across the US, under an agreement signed...

Deals this week: Ascend Therapeutics US, Tyme Technologies, Axsome Therapeutics

US FDA grants Fast Track designation for Shire’s SHP655

The US Food and Drug Administration (FDA) has granted Fast Track designation for Shire’s recombinant ADAMTS13 (SHP655 or previously known as BAX930) to treat acute episodes of hereditary...

US FDA grants Fast Track designation for Shire’s SHP655

British Columbia to provide public access to Gilead Sciences’ Epclusa for genotype 1-6 HCV

British Columbia to provide public access to Gilead Sciences’ Epclusa for genotype 1-6 HCV

Argenx and Broteio Pharma partner to develop antibody for autoimmune diseases

Netherlands-based biotechnology company argenx and Broteio Pharma, a joint venture between Prothix and Bioceros, have agreed to partner for the development of a therapeutic antibody for...

Argenx and Broteio Pharma partner to develop antibody for autoimmune diseases

US FDA approves Xadago to treat patients with Parkinson’s disease

US FDA approves Xadago to treat patients with Parkinson’s disease

Pierre Fabre and H-Immune to develop new cancer immunotherapies

French pharmaceutical company Pierre Fabre and H-Immune have entered a strategic research partnership to develop new cancer...

Pierre Fabre and H-Immune to develop new cancer immunotherapies

Ferrier Research Institute and BCFNZ to create new breast cancer vaccine

Victoria University of Wellington's Ferrier Research Institute and the Breast Cancer Foundation New Zealand (BCFNZ) have joined forces to create a new vaccine for breast cancer....

Ferrier Research Institute and BCFNZ to create new breast cancer vaccine

Emergent signs $100m BARDA contract to deliver BioThrax

Emergent signs $100m BARDA contract to deliver BioThrax

PCC acquires Intrathecal Therapy business from Mallinckrodt for $203m

PCC acquires Intrathecal Therapy business from Mallinckrodt for $203m

CannRx and iCAN:Israel-Cannabis form JV to launch sleep cannabis formulation

CannRx Technologies and iCAN:Israel-Cannabis have announced the formation of a joint venture (JV) in a bid to market ican.sleep, the sleep cannabis formulation....

CannRx and iCAN:Israel-Cannabis form JV to launch sleep cannabis formulation

Circassia to acquire US rights to Tudorza and Duaklir from AstraZeneca for $230m

UK-based specialty biopharmaceutical company Circassia Pharmaceuticals has reached an agreement for the transformational acquisition of US commercial rights to two chronic obstructive...

Circassia to acquire US rights to Tudorza and Duaklir from AstraZeneca for $230m
cachename:Newscachekey:rd-1665407042_1857678299_rd-488908060_1460672566_rd1460672566_371857150_ap1460672566_1857678299_946450448